Cargando…
Factors influencing postoperative anxiety and depression following Iodine-131 treatment in patients with differentiated thyroid cancer: A cross-sectional study
BACKGROUND: Differentiated thyroid cancer (DTC) often seriously impacts patients’ lives. Radionuclide Iodine-131 ((131)I) is widely used in treating patients with DTC. However, most patients know little about radionuclide therapy, and the treatment needs to be performed in a special isolation ward,...
Autores principales: | Su, Ying-Rui, Yu, Xiao-Peng, Huang, Li-Qun, Xie, Long, Zha, Jin-Shun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401505/ https://www.ncbi.nlm.nih.gov/pubmed/37547735 http://dx.doi.org/10.5498/wjp.v13.i7.486 |
Ejemplares similares
-
Postoperative anxiety and depression in surgical gastric cancer patients: their longitudinal change, risk factors, and correlation with survival
por: Liu, Ping, et al.
Publicado: (2022) -
Iodine-131 and Thyroid Function
por: Sun, Wenjie
Publicado: (2014) -
DIFFERENTIATED THYROID CANCER IN PEDIATRIC POPULATION (≤18 YEARS): POSTOPERATIVE TREATMENT WITH RADIOACTIVE IODINE (I-131)
por: Prpić, Marin, et al.
Publicado: (2019) -
Radioactive Body Burden Measurements in (131)Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body (131)Iodine Clearance
por: Ravichandran, Ramamoorthy, et al.
Publicado: (2014) -
Iodine-131: An Effective Method for Treating Lymph Node Metastases of Differentiated Thyroid Cancer
por: He, Ying, et al.
Publicado: (2016)